Techniques in flow cytometry/cell sorting were used to characterize the effects of benzene and its metabolites on subpopulations of bone marrow cells. Treatment of male Balb/c mice with benzene (880 mg/kg) or a combination of its metabolites, hydroquinone and phenol (50 mg/kg), resulted in a 30 to 40% decrease in bone marrow cellularity. Flow cytometric analysis revealed two supopulations of bone marrow cells that could be distinquished by their size and density or granularity. The larger, more dense subpopulation was found to consist predominantly of macrophages and granulocytes as determined by monoclonal antibody binding and by cell sorting. Benzene treatment had no selective cytotoxic effects on subpopulations of bone marrow cells. To determine if benzene treatment activated bone marrow phagocytes, we quantified production of hydrogen peroxide by these cells using the fluorescent indicator dye, 2',7'-dichlorofluorescin diacetate.
Introduction
Benzene is a potent bone marrow toxin. Acute treatment of experimental animals with benzene or its metabolites results in a decrease in bone marrow cellularity, as well as in impaired hematopoiesis and immune system functioning (1) (2) (3) (4) (5) (6) (7) . The mechanisms underlying these effects are unknown, but may involve a direct action of benzene or its metabolites on specific cellular components of the bone marrow.
Recently, it has been proposed that bone marrow stromal cells, in particular, macrophages, may represent a primary cellular target for benzene (8) (9) (10) (11) . These cells are known to release a variety of cytokines and growth factors that modulate the proliferation and activation of stem cells (12, 13) . Following tissue injury or antigenic stimulation, bone marrow macrophages, like other mononuclear phagocytes, become activated. These cells display enhanced functional and biochemical responsiveness and release elevated levels of cytokines (14) . Activated phagocytes also produce highly reactive and potentially toxic oxygen intermediates including superoxide anion, hydrogen peroxide, and hydroxyl radical (14) (15) (16) (17) . Activation 
Measurement of Phagocyte Oxidative Metabolism
Hydrogen peroxide production by bone marrow phagocytes was monitored using the indicator dye, 2',7'-dichlorofluorescein diacetate (DCFH-DA, Molecular Probes, Inc.) as previously described (15) (16) (17) (18) (population 1) and a smaller, less dense population (population 2). Treatment of mice with benzene or its metabolites had no effect on the light scatter properties of the bone marrow cells (not shown).
To further characterize these subpopulations, we used the monoclonal antibody, Mac-1. This antibody binds to the CR3 receptor on mature mouse macrophages and granulocytes. By indirect immunofluorescence and flow cytometry, we found that only subpopulation 1 bound the Mac-1 antibody (Fig. 3) . Sorting and microscopic examination of this subpopulation confirmed that it consisted predominantly of macrophages, monocytes, and granulocytes (not shown). Benzene had no effect on Mac-1 binding to the cells, conflrming that the proportion of macrophages and granulocytes in the bone marrow was unaffected by treatment of the mice (not shown). 2 and 3.) Hydrogen peroxide production by this subpopulation was then quantified. We found that basal levels of hydrogen peroxide production by Mac-1 positive cells from control and treated mice were similar (Fig. 4) . In contrast, phagocytes (Mac-1 positive cells) from benzene treated mice produced 50% more hydrogen peroxide in response to the phorbol ester tumor promoter, TPA, than did cells from control animals (Fig. 4) . Similar results were observed with cells obtained from the hydroquinone-phenol treated mice (not shown). In separate studies, we also found that the production of hydrogen peroxide by bone marrow phagocytes in response to TPA was inhibited by pretreatment of the cells for 5 min with 1 ,uM catalase (not shown). These results demonstrate that bone marrow phagocytes from benzene-treated mice are activated.
Discussion
Activated phagocytes are characterized by altered morphology, enhanced functional capacity, and release of reactive mediators. Although it is generally assumed that this results in more rapid destruction of foreign antigens, recent evidence suggests that the release of reactive mediators from phagocytes may also contribute to tissue injury (19, 20) . In the present studies we characterized macrophages and granulocytes isolated from bone marrow of mice treated with benzene, or its metabolites, hydroquinone and phenol, and determined if they were activated. We termined morphologically and by Mac-1 binding. This suggested that the cytotoxic effects of benzene on bone marrow cells were not selective. In addition, although there were no obvious morphological differences between the bone marrow cell types as determined by light microscopy, phagocytes from benzene-treated mice produced 50% more hydrogen peroxide following stimulation with TPA than did cells from control mice and thus, may be considered activated.
Reactive oxygen intermediates such as superoxide anion and hydrogen peroxide have been implicated as primary mediators of macrophage-induced cellular injury and may play a role in benzene-induced cytotoxicity. Following stimulation, activated phagocytes produce superoxide anion, which can react with water and other molecules to generate hydroperoxy-and hydroxyl radicals (19, 20) . These radicals are highly toxic and can initiate membrane lipid peroxidation reactions and induce direct damage to cellular macromolecules. Changes in membrane lipid composition such as those induced by lipid peroxidation can lead to alterations in cell membrane permeability, disruption of cellular homeostasis, and eventually to cell death. Thus, the decrease in bone marrow cellularity observed following benzene exposure may be mediated, at least in part, by oxygen radicals generated from activated bone marrow phagocytes.
Bone marrow macrophages activated by benzene have also been reported to release elevated levels of interleukin-1, as well as other cytokines that can stimulate proliferation and differentiation of bone marrow stem cells and stromal cell production of growth factors (11) . This can lead to increased proliferation of subpopulations of stem cells that may contribute to the development of benzene-induced leukemia.
Based on these results, we propose a model of benzeneinduced bone marrow toxicity (Fig. 5) 
